Health-care companies fell as traders retreated from the high-risk biotech niche.
The iShares Nasdaq Biotech index fell by roughly 2.5%, as an oil spike sparked a flight from risk.
German drug maker Merck KGaA forecast currency headwinds would continue to weigh on its earnings this year, as the life-sciences and chemical company prepares for a leadership change.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-05-26 1742ET



















